Cai Q, Guo R, Chen D, Deng Z, Gao J
J Nanobiotechnology. 2025; 23(1):178.
PMID: 40050980
PMC: 11884119.
DOI: 10.1186/s12951-025-03254-9.
Tang W, Zhou M, Lu C, Qi L, Zhang Y, Tang Y
Eur J Nucl Med Mol Imaging. 2025; .
PMID: 39985618
DOI: 10.1007/s00259-025-07140-2.
Li Y, Yang X, Wei Z, Niu H, Wu L, Chen C
Pharmaceutics. 2025; 17(1).
PMID: 39861683
PMC: 11769538.
DOI: 10.3390/pharmaceutics17010034.
Nikitovic D, Kukovyakina E, Berdiaki A, Tzanakakis A, Luss A, Vlaskina E
Cancers (Basel). 2024; 16(22).
PMID: 39594723
PMC: 11592346.
DOI: 10.3390/cancers16223768.
You J, Guo Y, Dong Z
Pharmaceutics. 2024; 16(9).
PMID: 39339228
PMC: 11435007.
DOI: 10.3390/pharmaceutics16091192.
Beyond Transduction: Anti-Inflammatory Effects of Cell Penetrating Peptides.
Lopuszynski J, Wang J, Zahid M
Molecules. 2024; 29(17).
PMID: 39274936
PMC: 11397606.
DOI: 10.3390/molecules29174088.
Construction and utilization of a new generation of bacteriophage-based particles, or TPA, for guided systemic delivery of nucleic acids to tumors.
Gay L, Suwan K, Hajitou A
Nat Protoc. 2024; .
PMID: 39237829
DOI: 10.1038/s41596-024-01040-9.
Computational modeling study of IL-15-NGR peptide fusion protein: a targeted therapeutics for hepatocellular carcinoma.
Fatima T, Mubasher M, Rehman H, Niyazi S, Alanzi A, Kalsoom M
AMB Express. 2024; 14(1):91.
PMID: 39133343
PMC: 11319546.
DOI: 10.1186/s13568-024-01747-8.
Harnessing the potential of hydrogels for advanced therapeutic applications: current achievements and future directions.
Lu P, Ruan D, Huang M, Tian M, Zhu K, Gan Z
Signal Transduct Target Ther. 2024; 9(1):166.
PMID: 38945949
PMC: 11214942.
DOI: 10.1038/s41392-024-01852-x.
Advances in Receptor-Mediated, Tumor-Targeted Drug Delivery.
Large D, Soucy J, Hebert J, Auguste D
Adv Ther (Weinh). 2024; 2(1).
PMID: 38699509
PMC: 11064891.
DOI: 10.1002/adtp.201800091.
In Vivo Imaging of Acute Hindlimb Ischaemia in Rat Model: A Pre-Clinical PET Study.
Farkasinszky G, Peline J, Karolyi P, Racz S, Denes N, Papp T
Pharmaceutics. 2024; 16(4).
PMID: 38675203
PMC: 11054801.
DOI: 10.3390/pharmaceutics16040542.
iRGD-targeted Physalis Mottle Virus-like Nanoparticles for Targeted Cancer Delivery.
Barkovich K, Zhao Z, Steinmetz N
Small Sci. 2024; 3(8).
PMID: 38465197
PMC: 10923535.
DOI: 10.1002/smsc.202300067.
Toxicity Studies of Cardiac-Targeting Peptide Reveal a Robust Safety Profile.
Sahagun D, Lopuszynski J, Feldman K, Pogodzinski N, Zahid M
Pharmaceutics. 2024; 16(1).
PMID: 38258084
PMC: 10818749.
DOI: 10.3390/pharmaceutics16010073.
The power of phages: revolutionizing cancer treatment.
Islam M, Fan J, Pan F
Front Oncol. 2023; 13:1290296.
PMID: 38033486
PMC: 10684691.
DOI: 10.3389/fonc.2023.1290296.
Anti-Cancer Properties of Flaxseed Proteome.
Merkher Y, Kontareva E, Alexandrova A, Javaraiah R, Pustovalova M, Leonov S
Proteomes. 2023; 11(4).
PMID: 37987317
PMC: 10661269.
DOI: 10.3390/proteomes11040037.
Phyllanthi Tannin Loaded Solid Lipid Nanoparticles for Lung Cancer Therapy: Preparation, Characterization, Pharmacodynamics and Safety Evaluation.
Wang B, Wu K, Liu R, Huang Y, Chang Z, Gao Y
Molecules. 2023; 28(21).
PMID: 37959818
PMC: 10647271.
DOI: 10.3390/molecules28217399.
Radiolabeled NGR-Based Heterodimers for Angiogenesis Imaging: A Review of Preclinical Studies.
Trencsenyi G, Halmos G, Kepes Z
Cancers (Basel). 2023; 15(18).
PMID: 37760428
PMC: 10526435.
DOI: 10.3390/cancers15184459.
From antimicrobial to anticancer: the pioneering works of Prof. Luiz Rodolpho Travassos on bioactive peptides.
Koskela S, Figueiredo C
Braz J Microbiol. 2023; 54(4):2561-2570.
PMID: 37725261
PMC: 10689714.
DOI: 10.1007/s42770-023-01118-8.
Challenges and Opportunities Associated With Drug Delivery for the Treatment of Solid Tumors.
Paresishvili T, Kakabadze Z
Oncol Rev. 2023; 17:10577.
PMID: 37711860
PMC: 10497757.
DOI: 10.3389/or.2023.10577.
Cardiomyocyte-Targeting Peptide to Deliver Amiodarone.
Zahid M, Weber B, Yurko R, Islam K, Agrawal V, Lopuszynski J
Pharmaceutics. 2023; 15(8).
PMID: 37631321
PMC: 10459552.
DOI: 10.3390/pharmaceutics15082107.